GEMAC - Corporate

Mission statement

Company profile
Business strategy
Technology platform

History

Executive committee

Scientific board

Collaborations

Investors



> GEMAC home.
GEMAC - Scientific board

  • Prof. Lucien Israël, MD, Emeritus professor of cancer research, Member of the French Institute.
  • Dr. Pablo Villoslada, MD, Neurologist, Clinica Universitaria de Navarra.
  • Prof. Jean Sibilia, MD, Rheumatologist, chair of Rheumatoid department of Strasbourg Hospital, co-founder of the largest European rheumatoid arthritis immunology data bank.
  • Prof. Luc Grislain, Pharm-D, Chair of University of pharmacy of Bordeaux, Groupe BERTIN CSO, galenic expert.
  • Dr. Yves Tillet, Pharm-D, 20 years experience as expert for the government (Afssaps, Anvar) and pharma companies (clinical development).
  • Prof. Jean-Robert Rapin, Pharm-D, Bourgogne University, chair of neuro-functional pathologies, consultant for private companies (BIOGEN) and government (MS committee, Anvar).